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Spermidine-spermineN1-acetyltransferase (SSAT) is induced
in response to an elevation in intracellular polyamine pools. The
increased enzyme activity is the result of an increase in gene
transcription, mRNA translation, and protein stability. Induc-
tion of SSAT by polyamine analogues can lead to intracellular
polyamine depletion and apoptosis. The mechanism by which
polyamines alter the translational efficiency of SSAT mRNA is
not well understood. In this study, we investigated the regula-
tion of SSAT translation by the polyamine analogue N1,N11-di-
ethylnorspermine (DENSPM). DENSPM induced expression of
bothFLAG-taggedSSATandSSAT fused toRenilla luciferase in
a time- and concentration-dependent manner. This effect was
not inhibited by actinomycin D indicating that changes in gene
transcription did not explain the enhanced expression in the
presence of DENSPM. Furthermore, because FLAG-SSAT did
not contain the 5- or 3-untranslated regions of SSAT, transla-
tional regulation involved the coding sequence only. By con-
trast, cycloheximide completely inhibited induction by
DENSPM, indicating a requirement for new protein synthesis.
Deletion constructs identified two regions of the SSAT protein-
coding RNA sequence that conferred polyamine responsive-
ness. Using these regions as probes in RNA electrophoretic
mobility shift assays, we observed specific binding of a cytoplas-
mic protein. In addition, we found that the interaction between
the RNA probes and the binding protein could be inhibited by
DENSPM in a concentration-dependent manner. These results
suggest that polyamines regulate SSAT mRNA translational
efficiency by inhibiting a repressor protein from binding to
regions of the coding sequence of the SSAT transcript.
Spermidine-spermine N1-acetyltransferase (SSAT)2 is a key
enzyme in the degradation of the essential polyamines spermi-
dine and spermine (1, 2). Normally, the intracellular level of
SSAT is low, but it can be rapidly induced by elevating intracel-
lular polyamine concentrations (3) or by treating cells with
polyamine mimetics such as N1,N11-diethylnorspermine
(DENSPM) or N1,N12-bis(ethyl)spermine (4, 5). SSAT expres-
sion is regulated at several different levels (5, 6). Gene transcrip-
tion is increased by polyamines via an Nrf-2-dependent path-
way, leading to an increase in SSAT mRNA (7). Moreover,
polyamines stabilize SSAT mRNA (6) and increase transla-
tional efficiency (5). Finally, elevated polyamine levels can lead
to a stabilization of the SSAT protein by inhibiting its polyubiq-
uitination and targeting to the proteasome (8). N-terminal sub-
stituted polyamine analogues are not substrates for SSAT but
appear to mimic the endogenous polyamine and cause an
increase in intracellular SSAT activity that can be 1000-fold
higher than that in untreated cells. The elevation in SSAT levels
leads to a depletion of intracellular polyamines and induction of
apoptosis (4). The candidate drug DENSPM is currently under
development as an anti-cancer agent (9, 10).
The regulation of SSAT mRNA translation by polyamines
is not fully understood. Fogel-Petrovic and coworkers (11)
showed that cycloheximide can increase SSAT mRNA in
Malme-3 M cells, but removal of the protein synthesis inhib-
itor was not accompanied by an increase in enzyme activity.
However, addition of polyamines led to an increased rate of
SSAT translation, suggesting that protein synthesis required
polyamines. Similarly, Parry and coworkers (5) reported that
N1,N12-bis(ethyl)spermine increased the amount of SSAT
mRNA associated with the protein-synthesizing 80 S mono-
somes. They also concluded from deletion studies of an
SSAT expression construct that the region of the mRNA
responsive to N1,N12-bis(ethyl)spermine was located within
the protein coding sequence. Thus, SSAT translation
appears to be inhibited at low polyamine concentration, and
this inhibition is released when polyamine levels are
increased.
SSAT activity is induced by a number of physiological
stimuli, including oxidative stress (12), x-ray irradiation
(13), insulin-like growth factor-I (14), cytotoxins (15), and
heat shock (16). Some of these stimuli do not appear to alter
mRNA levels, suggesting that co- and/or post-translational
mechanisms predominate. In the present study, we have
investigated the translational regulation of the SSAT mRNA
by DENSPM using two models, FLAG-tagged SSAT and
SSAT fused to luciferase. Sequences located within the pro-
tein-coding region, and in close proximity to both the start
and stop codons, are essential for the translational induction
of SSAT transcript. We provide evidence for the binding of a
cytosolic protein to the SSAT mRNA that can be displaced
by DENSPM.
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EXPERIMENTAL PROCEDURES
Cloning of SSAT 5-UTR and Coding Region—The SSAT
5-UTRand various lengths of the coding sequencewere cloned
upstream and in-frame with the Renilla luciferase gene located
in the XhoI/XbaI sites of pcDNA3.1 (rLuc). Initially, the SSAT
5-UTR and the entire coding region except the terminal lysine
and stop codon were amplified from a human breast cancer
cDNA library (Prof. Peter Leedman, Western Australian Insti-
tute for Medical Research) using primers F1 and R1 (see sup-
plemental Table S1 for oligonucleotides used in this study) and
cloned into the NheI and BamHI sites of the vector pGL3 (Pro-
mega, Madison, WI). It was then removed by digestion with
KpnI/BamHI and cloned into the same sites in rLuc such that
the SSAT and luciferase sequences were in-frame to generate
rLucSSAT510. Deletions of the coding region were achieved by
amplifying SSAT using a common forward primer F2 and dif-
ferent reverse primers (R2, R3, R4, and R5), which were
designed to generate products that contained the entire
5-UTRonly or togetherwith 333, 166, or 68 bases of the coding
region, respectively. The resulting constructs were named
rLucSSATUTR, rLucSSAT333, rLucSSAT166, and rLucSSAT68
(shown in Fig. 1B).
To make FLAG-tagged constructs, the coding region of
SSAT was amplified using rLucSSAT510 as template and prim-
ers F3 and R6. Reverse primer R6 added the terminal lysine and
stop codon missing from rLucSSAT510. The entire SSAT cod-
ing region was cloned into the HindIII and BamHI sites of
p3XFLAG-CMV-7.1 expression vector (Sigma) yielding FLAG-
SSAT513. A series of 3 deletion constructs was made using the
common forward primer F3 and various reverse primers (R7,
R8, R9, and R10), which produced products containing the first
504, 498, 482, or 486 bases of the SSAT coding region, respec-
tively. These constructs were named FLAG-SSAT504, FLAG-
SSAT498, FLAG-SSAT492, and FLAG-SSAT486. A series of 5
deletion constructs was made using various forward primers
(F4, F5, and F6) with the common reverse primer R6, which
produced products missing the first 15, 30, or 45 bases of the
coding region, respectively. These constructs were named
FLAG-SSAT15–513, FLAG-SSAT30–513, and FLAG-SSAT45–513.
In addition, FLAG-tagged SSAT constructs were made that
contained premature stop codons or basemutations. The prim-
ers used to make these constructs are shown in supplemental
Table S1, and the location of premature stop codons and base
mutations are shown in Fig. 5B. Constructs were verified by
DNA sequencing.
Cell Culture and Transient Transfections—HeLa (human
cervical adenocarcinoma) cells were obtained from ATCC
(Manassas, VA) and cultured in RPMI 1640 supplemented with
10% fetal bovine serum and incubated at 37 °C in an atmo-
sphere of 5% CO2 in air.
For luciferase studies, cells were seeded at a density of 2.5
105 cells/well (24-well plate) and incubated overnight at 37 °C.
Cells were cotransfected in the absence of fetal bovine serum
with 1 g of rLucSSAT plasmid and 0.1 g of the internal con-
trol plasmid pGL3-basic (Promega) using Lipofectamine 2000
(Invitrogen) according to the manufacturer’s instructions. After
24 h, cells were treated with up to 100 M DENSPM (a kind gift
fromDr.Carl Porter, Roswell ParkCancer Institute, Buffalo) for
a further 24 h. Cells were thenwashed and assayed for luciferase
activity using a Dual Luciferase Kit (Promega). For FLAG stud-
ies, cells were seeded and transfected as above with 1 g of
FLAG-SSAT plasmids, unless stated otherwise. Following
transfection, cells were incubated overnight at 37 °C, and then
treated with 10 M DENSPM or vehicle for 4 h. In some exper-
iments, cells were treated with actinomycin D (5 g/ml) or
cycloheximide (10 g/ml). Cells were washed with phosphate-
buffered saline and harvested by scraping into 0.4 ml of 20 mM
Tris/1 mM EDTA buffer (pH 7.4) containing 1 mM dithiothrei-
tol. Cells were then disrupted on ice by sonication, and the
supernatants were cleared by centrifugation for 10 min at
16,000  g (4 °C). Protein concentrations were determined by
the method of Bradford (Bio-Rad), and equal amounts (10 g)
of each sample were separated on 12% SDS-polyacrylamide
gels, transferred to nitrocellulose, and immunoblotted using
anti-FLAG-M2 HRP monoclonal antibody (Sigma).
MG132 Treatment and Immunoprecipitation—HeLa cells
were seeded at a density of 1 106 cells/well (6-well plate) and
co-transfected with 1g of pcDNA3-HA-ubiquitin and 2g of
either FLAG-SSAT513 or FLAG-SSAT504 plasmid. After an
overnight incubation, cells were co-treated with 10 M
DENSPM and 5 M MG132 (Calbiochem) or vehicle (Me2SO)
and incubated for a further 16 h. Cells were washed twice with
phosphate-buffered saline and harvested by scraping into 0.8
ml of 20 mM Tris/1 mM EDTA buffer (pH 7.4) containing 1 mM
dithiothreitol. Cells were then disrupted on ice by sonication,
and the supernatants were cleared by centrifugation for 10 min
at 16,000 g (4 °C). Anti-FLAG-M2 monoclonal antibody (10
g, F 3165, Sigma) was added, and the supernatants were
rotated for 2 h at 4 °C. Protein G-Sepharose 4B (P 3296, Sigma)
was then added, and the lysates were rotated for a further 1 h at
4 °C. Immunoprecipitates were collected by centrifugation, and
the beads were washed three times with phosphate-buffered
saline. The recovered proteins were separated on 12% SDS-
polyacrylamide gels, transferred to nitrocellulose, and immu-
noblotted using anti-HAantibody (H6908, Sigma) according to
the manufacturer’s instructions.
RNA Extraction, Reverse Transcription, and Real-time PCR—
For RNA studies, HeLa cells were seeded at 1  106 cells/well
(6-well plate) and transfected with 2.5 g of FLAG-SSAT513
plasmid. Cells were then incubated for 4 h in the absence or
presence of 10 M DENSPM, and total RNA was extracted
using TRIzol reagent (Invitrogen) as outlined in the manufac-
turer’s instructions. First strand cDNA was synthesized using
SuperScript II reverse transcriptase (Invitrogen) as per the
manufacturer’s protocol. Reactions lacking reverse tran-
scriptase also were performed to ensure no plasmid DNA con-
tamination. Expression levels of FLAG-SSAT mRNA were
quantified using the iCycler iQ Real-time PCR Detection Sys-
tem (Bio-Rad). First strand cDNA was amplified using specific
primers for FLAG-SSAT (F10 andR7) or-actin (F11 andR21).
Reactions contained iQ Supermix (Bio-Rad), 6 pmol of each
primer, and 1 l of cDNA in a final volume of 25 l. Samples
were amplified using the following conditions: initial denatur-
ation at 95 °C for 3min, followed by 40 cycles of denaturation at
95 °C for 15 s, annealing at 50 °C for 15 s, and extension at 72 °C
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for 30 s. Amelting curve was obtained to verify specificity of the
PCR. Samples were analyzed by the comparative CT method.
In Vitro Transcription/Translation—Reactionmixtures con-
tained 1 g of rLucSSAT510 DNA and 40 l of rabbit reticulo-
cyte lysate (TNT Quick Coupled Transcription/Translation
System, Promega), in a total volume of 50l. Initially, reactions
were incubated at 30 °C for 30min in the absence ofmethionine
to synthesize transcript. Then, actinomycin D was added to a
final concentration of 5 g/ml to stop the transcription. Reac-
tions were divided into two aliquots containing equal amounts
of mRNA, and DENSPM (50 M) or an equal volume of vehicle
was added to each aliquot. The paired reactions were pre-
warmed, and protein synthesis was initiated by the addition of
20 Mmethionine. Aliquots (5 l) were removed at 0, 5, 10, 15,
and 30min and boiled immediately in Laemmli buffer. Samples
were then separated on 12% SDS-polyacrylamide gels, trans-
ferred to nitrocellulose, immunoblotted using anti-Renilla
luciferase monoclonal antibody (MAB4410, Chemicon), and
quantified by densitometry (Quantity One software, Bio-Rad).
Preparation of Cytoplasmic Extracts—HeLa cells were
washed with cold phosphate-buffered saline and scraped into
cytoplasmic extraction buffer (10 mM HEPES (pH 7.2), 3 mM
MgCl2, 40 mM KCl, 5% glycerol, 0.2% Nonidet P-40, 1 mM di-
thiothreitol) containing protease inhibitor mixture (Sigma).
Cell extracts were incubated on ice for 20 min and then centri-
fuged at 16,000 g for 10 min at 4 °C, and the supernatant was
retained. Extract was used immediately or snap-frozen in liquid
nitrogen and stored at 80 °C until required. Protein concen-
trations were determined by the Bradford method (Bio-Rad).
Preparation of RNA Transcripts—Fragments of the SSAT
5 coding region were amplified by PCR using rlucSSAT510
as template and the common forward primer F7 and the
reverse primers R16, R17, and R18. PCR products were
digested with BamHI and HindIII and cloned into the same
sites of pBluescript II KS (Stratagene) in the T7 sense orien-
tation, giving the constructs P1–42, P1–77, and P1–165, where the
number indicates the number of bases of the SSAT insert
(beginning at the start codon). Fragments of the SSAT3 coding
region were also amplified using the common reverse primer
R19 and the forward primers F8 and F9, giving the constructs
P433–513 and P333–513. P333–492 was made using forward primer
F9 and reverse primer R20. All constructs were then linearized
with HindIII and used as templates in in vitro transcription
reactions. Linearized templateswere transcribed usingT7RNA
polymerase (Invitrogen) in reactions containing [-32P]UTP
(3000 Ci/mmol, GE Healthcare) as described elsewhere (17).
Full-length transcripts were isolated on 6% urea/acrylamide
gels, eluted for 3 h at 22 °C in 0.5 M ammonium acetate/1 mM
EDTA, and ethanol-precipitated to recover the RNA. Unla-
beled RNA transcripts were synthesized as above but with 2.5
mM UTP.
REMSAs—Binding reactions (10l) contained 10g ofHeLa
cytoplasmic extract and 100,000 cpm of 32P-Riboprobe (P1–42,
P1–77, P1–165, or P333–513) and were performed as described
elsewhere (17). Briefly, reactions were incubated for 30 min at
22 °C, 0.3 unit of RNase T1 (Roche Applied Science) was added
for 10 min, and the followed by heparin (Sigma, final concen-
tration of 5 g/l unless stated otherwise) for 10 min. Samples
were then electrophoresed on 5% native acrylamide gels, dried,
and analyzed with a Personal Molecular Imager FX (Bio-Rad).
In some assays, cell extracts were preincubated for 10 min at
22 °C with nonspecific or specific competitor unlabeled RNA
(100molar excess) or with DENSPM (0–50 M).
RESULTS
SSAT-luciferase Fusion Protein Is Induced by DENSPM—To
determinewhether SSAT fused to a reporter proteinwas induc-
ible by DENSPM treatment, human cervical HeLa cells were
transfected with rLucSSAT510 and then treated with increasing
concentrations of drug. The SSAT-luciferase fusion protein
showed almost a 10-fold increase in expression, with an EC50 of
2.7 0.4 M (Fig. 1A). A series of SSAT ORF deletion reporter
constructs was generated (Fig. 1B) in an attempt to locate the
region of SSAT that was responsive to DENSPM. The basal
expression levels of the longer fusion proteins rLucSSAT333
and rLucSSAT166 were not different from rLucSSAT510,
whereas those of rLucSSAT68 and rLucSSATUTR were signifi-
cantly greater than rLucSSAT510 (Fig. 1C). The observed differ-
ences in basal expression levels were a result of differing fusion
protein half-lives (Table 1). None of the C-terminal rLucSSAT
deletion proteins were induced by DENSPM, including the
control rLuc vector (Fig. 1C). Similar results were obtained
using the human melanoma cell line MM2058 (data not
shown). These results suggest that the induction of SSAT is
dependent on the presence of the 3 third of the coding region.
To investigate the effect of DENSPM on the stability of SSAT-
luciferase proteins, the inducible rLucSSAT510 and the non-
inducible rLucSSAT333 proteins were treated with cyclohexi-
mide, and their half-lives were determined in the absence or
presence of DENSPM. DENSPM had no significant effect on
the half-life of either fusion protein (Table 1).
DENSPM Enhances the Translation of SSAT-luciferase
Fusion Protein in Vitro—The effect of DENSPM on the trans-
lation of rLucSSAT510 was investigated using an in vitro tran-
scription/translation system. First, mRNA was synthesized
from rLucSSAT510 plasmid in a reaction containing rabbit
reticulocyte lysate, but lacking methionine. Actinomycin D (5
g/ml) was added to stop the transcription, and the reaction
was then divided into two equal aliquots, one treated with 50
M DENSPM and the other with an equal volume of vehicle.
Protein synthesis was initiated by the addition of methionine
and the rate of protein synthesis measured over 30 min. Ali-
quots taken from each paired reaction at 0, 5, 10, 15, and 30
min were boiled immediately in Laemmli buffer and sub-
jected to Western blot using an anti-Renilla luciferase anti-
body. The blots were quantified by densitometry, and the
slope of the linear part of the curves was used to measure the
rate of rLucSSAT protein synthesis (Fig. 2). The rate of pro-
tein synthesis in the presence of DENSPM was significantly
greater than that in its absence (74.4  3.4 and 19.8  2.1
density units/min, respectively).
Induction of FLAG-tagged SSAT by DENSPM Is via Transla-
tional Regulation—An inherent problem with the luciferase
fusion proteins used in the first part of this study is the possi-
bility of direct interference with the luciferase enzyme activity
by the attached SSAT fragments. For that reason, FLAG-tagged
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SSAT was used as a model for the remainder of the study, and
protein levels rather than enzyme activities were measured.
Full-length SSAT was cloned into a FLAG vector (FLAG-
SSAT513) and expressed in HeLa cells to investigate the mech-
anism by which DENSPM induces SSAT expression. In the
absence of DENSPM treatment, no FLAG-SSAT protein was
detectable by Western blot using an anti-FLAG HRP antibody
(Fig. 3A). Upon DENSPM (10 M) treatment there was a time-
dependent increase in FLAG-SSAT protein production, with
near maximal levels occurring by 8 h (Fig. 3A). To determine
whether the induction of FLAG-SSAT required new mRNA
synthesis, cells were treated with actinomycin D (5 g/ml) for
10 min, and then with 10 M DENSPM for 4 h. Induction of
FLAG-SSAT by DENSPM was not affected by the presence of
actinomycin D (Fig. 3B). By contrast, when cells were treated
with the protein synthesis inhibitor cycloheximide (10 g/ml)
and DENSPM, induction was completely abolished (Fig. 3B).
To determine if FLAG-SSATmRNAwas present in the absence
of DENSPM, total RNA was extracted from control cells and
cells that had been treated with 10 M DENSPM for 4 h. Fol-
lowing reverse transcription, specific primers were used to
quantify FLAG-SSAT transcript levels by real-time PCR. Tran-
script levels were not increased in the presence of DENSPM
(Fig. 3C). In fact, transcript levels were reduced in the presence
of DENSPM,which is consistent with increased translation and
translation-dependent mRNA degradation (18). A previous
FIGURE 1. DENSPM induction of SSAT-luciferase fusion proteins.
A, DENSPM dose-response curve. HeLa cells were transiently transfected
with rLucSSAT510 and then treated with increasing amounts of DENSPM
for 24 h. Data are expressed as mean  S.E., n  4. B, schematic view of
rLucSSAT deletion constructs. C, effect of DENSPM on truncated SSAT-
luciferase fusion proteins. HeLa cells were transfected with the various
rLucSSAT deletion constructs and then treated with either vehicle (open
bars) or 10 M DENSPM (closed bars) for 24 h. Data are expressed as
mean  S.E., n  4. *, indicates significantly different (p 	 0.05) from
untreated controls.
TABLE 1
Stability of SSAT-luciferase fusion proteins in HeLa cells
Constructs Fusion protein half-life
DENSPM DENSPM
h (mean S.E.)
rLuc-SSAT510 1.17 0.04 1.29 0.14
rLuc-SSAT333 1.29 0.11 1.31 0.12
rLuc-SSAT166 1.12 0.10 NDa
rLuc-SSAT68 1.91 0.10 ND
rLuc-SSATUTR 3.46 0.11 ND
rLuc 2.34 0.19 ND
aND, not determined.
FIGURE 2. In vitro translation of rLucSSAT fusion protein. Reactions con-
taining rabbit reticulocyte lysate and rLucSSAT510 plasmidwere incubated at
30 °C for 30 min to synthesize mRNA. Reactions were then treated with acti-
nomycinD (5g/ml) anddivided into twoaliquots containingequal amounts
of mRNA. One aliquot was treated with 50 M DENSPM (open squares),
whereas the other served as an untreated control (closed squares). Protein
synthesis was initiated by adding methionine to the prewarmed reactions.
Aliquots of each reactionwere removed at 0, 5, 10, 15, and 30min and imme-
diately boiled in Laemmli buffer. rLucSSAT fusion protein was detected by
Western blot using anti-Renilla Luciferase antibody and quantified by densi-
tometry (Quantity One software, Bio-Rad). The zero time points were sub-
tracted from subsequent samples.
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study by Parry and coworkers (5) also observed a decrease in
SSAT mRNA levels following polyamine analogue treatment.
This indicates that expression of FLAG-SSATmRNA has little
effect on SSAT protein levels. Combined, these results indicate
that translation of FLAG-SSAT mRNA is blocked in the
absence of DENSPM. In addition, because the SSAT 5- and
3-UTRswere not present in the plasmid, the translational con-
trol of SSAT by DENSPM is mediated by the protein coding
region, which is in agreement with a previous study (5).
Induction of FLAG-SSAT by DENSPM Is Not Due to Protein
Stabilization—SSAT is degraded via the ubiquitin/26 S protea-
some pathway (19), and it has been demonstrated that the
C-terminal MATEE amino acid motif plays a critical role in
polyamine-mediated stabilization of the protein (20). As a
result, the lack of FLAG-SSAT protein detected in cells not
treated with DENSPM may be due to rapid turnover of the
protein. To address this possibility, HeLa cells were transiently
transfected with plasmid containing either full-length SSAT
(FLAG-SSAT513) or a truncated construct (FLAG-SSAT504),
which produces a protein that is reported to be stabilized in the
absence of polyamine analogue (19). Cells were then treated
with 10 MDENSPM in the absence or presence of the protea-
somal inhibitor MG132 (20 M). In cells not treated with
DENSPMorMG132, no expression of either FLAG-SSAT513 or
FLAG-SSAT504 was observed (Fig. 4A). When MG132 was
added, a small amount of FLAG513 was observed in the absence
of DENSPM. This low level of translation may be due to the
presence of endogenous polyamines. In addition, no poly-
ubiquitinated products were observed in lysates from cells
treated with MG132 in the absence of DENSPM (Fig. 4B).
These data indicate that the lack of FLAG-SSAT protein
observed in the absence of DENSPM was not because of
rapid protein degradation.
FIGURE 3. Expression of FLAG-SSAT in HeLa cells. A, HeLa cells were tran-
siently transfectedwith pFLAG-SSAT513 plasmid, incubated for 24 h, and then
treatedwith DENSPM (10M) for up to 24 h. At the indicated times, cells were
lysed, and FLAG-SSAT detected by Western blot using anti-FLAG-M2 HRP
antibody. Densitometry was performed using Quantity One software (Bio-
Rad). B, HeLa cells were transiently transfected with pFLAG-SSAT513 plasmid
and incubated for 24 h. Cells were then treated with either actinomycin D (5
g/ml) or cycloheximide (10g/ml), or left untreated. After 10min, cellswere
treated with DENSPM (10 M) or vehicle for 4 h, and then lysed and FLAG-
SSATdetectedbyWesternblot.C, HeLa cellswere transiently transfectedwith
pFLAG-SSAT513 plasmid, incubated for 24 h, and then treated with DENSPM
(10 M) for 4 h. Total RNA was extracted and reverse transcribed, and FLAG-
SSATmRNAwasquantifiedby real-timePCR.Datawerenormalized to-actin
and expressed relative to control.
FIGURE 4. Effect of DENSPM on the stability of FLAG-SSAT proteins.
A, HeLa cells were transiently transfected with either pFLAG-SSAT513 or
pFLAG-SSAT504 plasmids, incubated for 24 h, and then treated with MG132
(20M) in the presence and absence of DENSPM (10M) for 16 h. FLAG-SSAT
proteins were detected using anti-FLAG-M2HRP antibody. B, HeLa cells were
transiently transfected with HA-ubiquitin and either pFLAG-SSAT513 or
pFLAG-SSAT504 plasmids, incubated for 24 h, and then treated with MG132
(20 M) in the presence and absence of DENSPM (10 M) for 16 h. Cells were
lysed and immunoprecipitated with anti-FLAG antibody, Western blotted,
and probed with anti-HA antibody. Polyubiquitinated products are shown.
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Sequences Essential for DENSPM Induction of SSAT Are
Located Both at the 5- and 3-Ends of the mRNA—To identify
the region of the SSAT mRNA involved in SSAT translational
induction, we constructed a series of FLAG-SSAT deletion
mutants and determined the effect of DENSPM in transiently
transfected HeLa cells (Fig. 5A). Because SSAT-luciferase
fusion protein studies indicated that the 3 third of theORFwas
important, initial deletions were of this region. The FLAG-
SSAT504 deletion had the same inducibility as full-length
FLAG-SSAT513 (Fig. 5A). The next shortest construct, FLAG-
SSAT498, was DENSPM-responsive but showed some leakiness
with a small amount of FLAG-SSAT protein being produced in
the absence of DENSPM. The FLAG-SSAT492 and FLAG-
SSAT486 constructs were not inducible by DENSPM with sim-
ilar amounts of FLAG-SSAT protein translated in the absence
and presence of DENSPM (Fig. 5A). These results suggest
that the coding sequence located between bases 492 and 504,
relative to the SSAT start codon, serves to repress transla-
tion in the absence of DENSPM. Deletions also were per-
formed on the 5-end of the SSAT ORF. FLAG-SSAT15–513
and FLAG-SSAT30–513 constructs were inducible by
DENSPM, but showed some leakiness with a small amount of
FLAG-SSAT protein being translated in the absence of
DENSPM (Fig. 5A). The FLAG-SSAT45–513 construct was
not responsive to DENSPM, and there were similar levels of
protein translated in the absence and presence of DENSPM
(Fig. 5A). These results show that
the first 45 bases of the SSAT cod-
ing region as well as the bases
between 492 and 504 are required
for DENSPM responsiveness.
Functional mRNA instability ele-
ments have been detected within
the coding regions of several
mRNAs (21). The bases located
between 492 and 504 of the SSAT
coding region bear resemblance to
an mRNA instability element iden-
tified in plasminogen activator
inhibitor type 2 as well as in five
other mRNAs (21). To investigate
the possibility that the involvement
of this sequence in DENSPM
responsiveness is due to inducible
stability of the SSAT transcript, a
number of different constructs were
made that contained in-frame pre-
mature stop codons. These con-
structs were transiently trans-
fected into HeLa cells, and the
effect on DENSPM inducibility
was examined. FLAG-SSAT498s,
FLAG-SSAT492s, and FLAG-SSAT486s
produce similar mRNAs to that of
the inducible construct FLAG-
SSAT504 but yield proteins identical
to constructs FLAG-SSAT498,
FLAG-SSAT492, and FLAG-SSAT486,
respectively (Fig. 5B). As observedwith FLAG-SSAT486, FLAG-
SSAT486s was not inducible by DENSPM, even though the
putative instability element was present in its mRNA sequence
(Fig. 5B). Two other constructs, FLAG-SSAT504
2 and FLAG-
SSAT504
8, contain silent mutations that alter the mRNA
sequence but yield identical protein to the DENSPM-inducible
FLAG-SSAT504. Both mutated constructs were DENSPM-re-
sponsive (Fig. 5B). Together, these results do not support the
concept that the sequence between 492 and 504 of the SSAT
coding region is an inducible stability element that confers
responsiveness to DENSPM.
DENSPM-displaceable RNA-binding Proteins Interact with
the Coding Region of SSAT mRNA—Folding analysis of the
SSAT mRNA using the modified method of Zucker (MFold
version 3.2) (22) predicted a number of stem-loops, including 2
in the first 165 bases of the protein coding region, and both
stem-loops were still predicted when only the first 165 bases
were folded separately (Fig. 6A). The start codon is located at
the base of the first stem-loop, and the entire folding of this
region resulted in a predicted change of free energy (
G) of
42.1 kcal/mol. Folding analysis of this region where the first
15, 30, or 45 bases weremissing resulted in amarked increase in

G values to 30.6, 24.4, and 17.2 kcal/mol, respectively.
When 15 or 30 bases were removed, SL1 and SL2 (see Fig. 6A)
remained but the structure of SL1 was altered. However, when
45 bases was removed, a single stem-loop was predicted that
FIGURE 5. DENSPM inducibility of FLAG-SSAT deletion proteins. A, HeLa cells were transiently transfected
with plasmids that produce FLAG-tagged full-length SSAT protein (FLAG-SSAT513), N-terminal (FLAG-SSAT15–513,
FLAG-SSAT30–513, and FLAG-SSAT45–513), or C-terminal (FLAG-SSAT504, FLAG-SSAT498, FLAG-SSAT492, and FLAG-
SSAT486) truncated SSAT proteins. After transfection, cells were treatedwithDENSPM (10M) or vehicle for 4 h,
and cell lysates were prepared and Western blotted using anti-FLAG HRP antibody. Densitometry was per-
formed using Quantity One software (Bio-Rad), and –fold induction is presented above each blot in parenthe-
ses. B, HeLa cells were transiently transfected with FLAG-SSAT plasmids containing premature stop codons
(FLAG-SSAT498s, FLAG-SSAT492s, and FLAG-SSAT486s) that produce truncated proteins but have similar mRNAs
to FLAG-SSAT504, or plasmids containing base changes in the SSAT mRNA (FLAG-SSAT504
2, FLAG-SSAT504
8)
but have the same protein sequence as FLAG-SSAT504. After transfection, cells were treated with DENSPM (10
M) or vehicle for 4 h, and cell lysates prepared and Western blotted using anti-FLAG HRP antibody.
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bore no resemblance to either SL1 or SL2. Together with the
FLAG-SSAT5 deletion data, this suggests that RNA secondary
structure may play an important role in the repression of SSAT
translation. Folding analysis of the SSATmRNA also predicted
the presence of two stem-loops in the final 180 bases of the
protein coding sequence, and the entire folding of this region
resulted in a 
G of48.6 kcal/mol (Fig. 6B). Progressive dele-
tion of the last 9, 15, or 21 bases from the 3-end resulted in only
minor changes in 
G values (47.6, 43.4, and 42.7 kcal/
mol, respectively). However, the secondary structure changed
considerably when 21 bases were removed, and SL4 (see Fig.
6B) was not predicted. When 15 bases were removed, SL4 was
predicted butwith slight structural alterations, andwhen only 9
baseswere removed, SL4was predicted and had the same struc-
ture as that predicted for the full-length sequence. Together
with the FLAG-SSAT 3 deletion data, this analysis supports a
role for RNA secondary structure in the regulation of SSAT
mRNA translation.
RNA stem-loops often form sites for interaction with RNA-
binding proteins that can regulate translational efficiency. To
determine whether the first 165 bases of the SSAT coding
region bound cellular protein(s), REMSAs were performed
using three different Riboprobes; P1–42, P1–77, and P1–165, con-
sisting of the first 42, 77, and 165 bases of the mRNA relative to
the translational start site, respectively (shown in Fig. 6A). Fig.
7A (right panel) shows a major band for the P1–165 probe that
remained evident as the stringency of the assay was increased.
By contrast, the P1–42 probe showed no specific binding (Fig.
7A, left panel), whereas the P1–77 probe appeared to bind cellu-
lar proteins at low stringency only (Fig. 7A, center panel) sug-
gesting that the affinity of the proteins for this probe was less.
The specificity of the RNA binding to the P1–165 probe was
demonstrated by inhibition with unlabeled P1–165 probe (Fig.
7B). Excess nonspecific RNA (Bluescript or tRNA) only
decreased binding slightly, and unlabeled P1–42 and P1–77 did
not inhibit the P1–165 shift to any greater extent than nonspe-
cific RNA (Fig. 7B).
To test whether one or more of the specific binding proteins
were affected by DENSPM, a dose-response study was under-
taken. DENSPM inhibited binding in a concentration-depend-
ent manner with 10 M decreasing the intensity of the specific
binding by 60% (Fig. 7C). Because stringency was controlled by
the amount of heparin added to the REMSA, we examined
whether nonspecific interactions between the cationic
DENSPM and the anionic heparin could account for these
observations. For this, a probe from the 3-UTRof the androgen
receptor (23) was used in a separate REMSA (Fig. 7D).
DENSPMup to 10M had no effect on the resulting shift of the
probe.Moreover, if DENSPMdid interact significantly with the
heparin, a decrease in stringency would result and a concomi-
tant increase in nonspecific bindingwould be expected, but was
not observed.
To assess whether the 3 region of the SSAT coding region
bound cellular protein(s), the Riboprobe P333–513 was subjected
to REMSA analysis. A single band was observed (Fig. 7E, first
lane) that represented specific binding, because it was com-
pletely competed by unlabeled P333–513 and only slightly com-
peted by excess nonspecific RNAs (Fig. 7E). In addition, the
specific binding was competed by unlabeled P433–513, which
consists of the last 80 bases of the SSATORF. This suggests that
protein binding only requires the last 80 bases of the SSAT
mRNA coding region. As was the case for P1–165, DENSPM
inhibited protein binding to P333–513 in a concentration-de-
pendentmanner with 10M decreasing the intensity of specific
binding by 80% (Fig. 7F). Concentrations of DENSPM of 10
M resulted in an apparent increase in specific binding, most
likely caused by DENSPM interactions with heparin, resulting
in a decrease in assay stringency.
Because DENSPM was unable to induce FLAG-SSAT when
the last 21 bases of the coding region were deleted (FLAG-
SSAT492), the ability of a shorter oligonucleotide competitor
equivalent, P333–492, to compete protein binding to the P333–513
Riboprobe in REMSA was assessed. Both unlabeled P333–513
and P333–492 (100 molar excess) inhibited specific protein
binding to the labeled P333–513 Riboprobe (Fig. 8A). In addition,
labeled P333–492 Riboprobe showed specific protein binding
similar to that observed for labeled P333–513 (Fig. 8B). These
data suggest that the binding of protein to the 3-end of the
coding sequence is not, by itself, sufficient to block translation.
However, because changes in either the 5 or 3 coding
sequences increased DENSPM-independent translation, it
appears that these two regions may interact in vivo. The possi-
bility that the same RNA-binding protein interacts with both
the 5- and 3-ends of the SSAT ORF was investigated. In
REMSA using labeled P1–165, specific binding was competed
not only by unlabeled P1–165 but also by P333–513. In a similar
manner, binding to labeled P333–513 was competed by both
unlabeled P333–513 and P1–165 (Fig. 8C). This suggests that the
same, or similar, proteinmay bind to both the 5 and 3-ends of
the SSAT coding sequence.
DISCUSSION
Polyamines play a critical role in cellular processes such as
growth, differentiation, and apoptosis. As a result, their intra-
cellular concentrations are tightly regulated. In the cell, the
FIGURE 6.Predicted RNA folding of SSAT. A, the secondary structure for the
first 165nucleotides of the SSAT coding sequencewas predictedusingMFold
(Ver. 3.2) (22) and contains two stem-loop structures, SL1 (
G30.5 kcal/
mol) and SL2 (
G9.8 kcal/mol). SL1 has the start AUG at its base (5). The
probes used in REMSAs are shown as P1–42, P1–77, and P1–165. B, the predicted
secondary structure for the last 180 nucleotides of the SSAT coding sequence
also contains two stem-loops, SL3 (
G  18.9 kcal/mol) and SL4 (
G 
27.9 kcal/mol). SL4 has the stop UGA at its base (3). The probes used in
REMSAs are shown as P433–513, P333–513, and P333–492.
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ability of endogenous polyamines such as spermine to regulate
the translation of SSAT and control its expression would pro-
vide an efficient mechanism for maintaining polyamine home-
ostasis. The presence of SSAT mRNA in a translationally
repressed state means that the cell can respond quickly to
restore polyamine homeostasis following an elevation in their
levels. If endogenous polyamines regulate SSAT translation,
stimuli that increase SSAT transcription would not alter SSAT
expression unless polyamine levels were also elevated.
Because SSAT induction can induce growth arrest as well as
apoptosis, it is a novel potential target for anticancer therapy
(24). Several polyamine analogues have been identified as
potent inducers of SSAT, including DENSPM. This drug has
progressed to Phase II clinical trials in renal cell carcinoma and
advanced breast cancer (25, 26). However, it has been previ-
ously reported that the response of
different cell types to DENSPM is
quite variable. Some cells show high
SSAT induction, and cytotoxicity, at
concentrations as low as 1 M (27),
whereas others require a drug con-
centration at least an order of mag-
nitude higher for induction (28, 29).
SSAT expression is regulated at sev-
eral levels, including translation (5,
11), which requires elevated poly-
amine levels for optimum protein
production.Thismayexplain thesyn-
ergy between polyamine analogs and
some conventional chemotherapies,
such as oxaliplatin, that increase
SSATmRNA (30).
Little is known about the molec-
ular mechanisms that underlie the
increase in translational efficiency
of SSAT mRNA in the presence of
polyamines. In the present study, we
have used SSAT-luciferase fusion
proteins and FLAG-tagged SSAT
proteins to characterize and inves-
tigate the polyamine-dependent
translational regulation of SSAT
mRNA. Initial experiments using
SSAT-luciferase fusion proteins
suggested that a motif located
within the 3 third of the coding
region serves to repress translation
in the absence of polyamines. The
induction of rLucSSAT510 fusion
protein by DENSPMwas not due to
protein stabilization, because the
half-life of the fusion protein was
not altered by the presence of
DENSPM. In addition, DENSPM
enhanced the translation of SSAT-
luciferase fusion protein in an in
vitro translation system.
In a study that addressed the role
of the 5- and 3-UTRs of the mRNA, Parry and coworkers
showed that neither of these regions of the transcript conferred
sensitivity to the analogue N1,N12-bis(ethyl)spermine (5). This
lack of involvement of the UTRs in the translational regulation
of SSAT was confirmed in the present study using FLAG-
tagged SSAT and DENSPM. When the coding region of SSAT
was cloned into a FLAG vector, no detectable protein was
expressed in the absence of DENSPM, even though consider-
able mRNA was present. Upon DENSPM treatment, FLAG-
SSAT protein was induced, but mRNA levels actually
decreased. This is consistent with increased translational activ-
ity. In addition, actinomycin D had no effect on the level of
FLAG-SSAT protein following DENSPM treatment. By con-
trast, induction was completely abolished by the presence of
the protein synthesis inhibitor cycloheximide, confirming a
FIGURE 7. Proteins bind specifically to the coding region of SSATmRNA. A, REMSAswere performed using
5gof cytoplasmic extract and 100,000 cpmof 32P-labeled P1–42, P1–77, or P1–165 transcripts, which contain the
first 42, 77, or 165 bases of the protein coding region of SSAT mRNA, respectively. Increasing amounts of
heparin (0, 1.25, 2.5, and 5g/l) were added to REMSAs to increase the stringency of the assay. B, competition
studies were performed by addition of unlabeled RNA (100molar excess) to the cytoplasmic extract prior
to incubation with 32P-labeled P1–165 Riboprobe. C, effect of DENSPM on the specific interaction of P1–165
Riboprobe with cytoplasmic extract. REMSAs were quantified by densitometry (Quantity One software) and
shown graphically. D, effect of DENSPM on the specific interaction of an androgen receptor Riboprobe with
cytoplasmic extract. E, REMSAswere performed using a 32P-labeled Riboprobe consisting of the last 180 bases
of the protein coding region of SSAT mRNA (P333–513). Competition studies were performed by addition of
unlabeledRNA (1000molar excess) to the cytoplasmic extracts prior to incubationwithRiboprobe. P433–513
contained the last 80 bases of the coding region of SSAT transcript. F, effect of DENSPM on the specific inter-
action of P333–513 Riboprobe with cytoplasmic extract.
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requirement for new protein synthesis. The ability of cyclohex-
imide to prevent the induction of FLAG-SSAT by DENSPM
suggests that induction is not a result of protein stabilization,
but rather a release of a translational block. The lack of involve-
ment of protein stabilization is further supported by experi-
ments using the proteasomal inhibitor MG132. SSAT is
degraded via the ubiquitin/26 S proteasome pathway (19). If, in
the absence ofDENSPM, the lack of FLAG-SSATprotein is due
to rapid protein degradation, then the addition of MG132
should result in the accumulation of polyubiquitinated prod-
ucts, and this was not observed. Furthermore, FLAG-SSAT504,
which reportedly produces a protein with enhanced stability
(19), is not present in the absence of DENSPM.Once DENSPM
has relieved the translational block and SSAT protein has been
synthesized, DENSPM may then function to stabilize the pro-
tein as has been reported in previous in vitro studies (8, 19).
Using a series of deletion constructs, we have identified two
polyamine-responsive regions within the SSAT coding mRNA.
Deletion of the first 45 bases of the coding region resulted in the
total loss of translational block and any induction by DENSPM.
Deletion of the last 21 bases of the coding region had the same
effect, indicating that both regions are essential for transla-
tional repression and DENSPM induction of SSAT. When the
folding of the first 165 bases wasmodeled, two stem-loops were
predicted. The first stem-loop contained the first 76 bases of the
coding sequence and the second contained bases89 to163.
The first stem-loop was independent of flanking sequences and
contained the translation start site at its base. Interestingly, this
region shows high homology between mammalian species
(84%) with most of the base variation occurring in bulges or
non-paired regions of the two predicted stem-loops. This sug-
gests that the secondary structure of the mRNA is conserved.
The moderately stable stem-loop structures present in the
regions of the SSAT coding mRNA important for DENSPM
responsiveness would not be sufficient to prevent translation
(5, 31), whereas a RNA-protein complex could conceivably
block translation.
The formation of stem-loops in mRNA can promote the
interaction with regulatory proteins that modulate transla-
tional efficiency as well as RNA stability (32). Using the 165-
base fragment from SSAT mRNA that contained both pre-
dicted stem-loops, we identified specific protein interactions by
REMSA. When the RNA fragment was truncated to include
only the first stem-loop, specific binding was still evident, but
the apparent binding affinity was considerably diminished, sug-
gesting that the second putative stem-loop is crucial. Specific
binding also was evident using the 3 region of the coding SSAT
mRNAinREMSA. Interestingly, deletionof the last 21basesof the
3 Riboprobe did not alter specific protein binding in REMSAs.
This was in contrast to FLAG-SSAT expression studies where
removalof the last 21bases resulted in translation in theabsenceof
DENSPM.This implies that, in isolation, protein binding to the 3
polyamine-responsive region is not solely responsible for the
translational block. Importantly, the interactions between the
cytoplasmic components and both the 5 and 3 regions of
the coding mRNA were inhibited by DENSPM. In addition,
REMSAcold competition studies indicated that the sameRNA-
binding protein was interacting with both the 5 and 3 regions.
These results suggest that both of these regions of the SSAT
codingmRNA bind to a repressor protein that can be displaced
by polyamines resulting in an increase in translational effi-
ciency. The in vitro translation studies suggest that the protein
involved in the repression of SSAT translation is present in
rabbit reticulocyte lysate, which could provide a convenient
source for its isolation and identification. Although there are
numerous examples of translational regulation by RNA-bind-
ing proteins, most interact with the 5-UTR or 3-UTR of their
target gene (32). Dihydrofolate reductase binds to its own
mRNA within the coding sequence and suppresses translation
(33). Moreover, repression can be reversed by the folate ana-
logue methotrexate. Cytoplasmic proteins also have been
shown to interact with translational control elements located in
the coding region of proopiomelanocortin (34) and thymidylate
synthase (35) mRNAs. We hypothesize that a polyamine-dis-
placable RNA-binding protein interacts with structural motifs
in both the 5- and 3-ends of the SSAT coding mRNA and
represses translation. The possibility of cross-talk between the
5- and 3-ends of the coding sequence via the RNA-binding
protein is plausible and could explain how removal of either the
5- or 3-end of the sequence allows translation to proceed in
the absence of DENSPM. Previous studies have shown that
cross-talk between motifs in the 3-UTR and events far
upstream is possible, occurring directly or via protein-protein
interactions (36, 37).
In summary, the current study has identified two regions of
the SSAT protein coding sequence that are involved in the
translational repression of SSAT in the absence of elevated
polyamine levels. It appears that a RNA-binding protein that
possibly interacts with stem-loop structures and blocks trans-
lation can be displaced by DENSPM, allowing translation to
proceed. It also appears that the 5 and 3polyamine-responsive
FIGURE8.Deletionof the last21basesof theSSATcoding regiondoesnot
affect protein binding in REMSA. A, competition studies were performed by
additionofunlabeledRNA(100molarexcess) tothecytoplasmicextractprior
to incubation with 100,000 cpm of 32P-labeled P333–513 Riboprobe. B, REMSAs
were performed using 5 g of cytoplasmic extract and 100,000 cpm of 32P-la-
beled P333–513 or P333–492. Increasing amounts of heparin (0, 2.5, and 5 g/l)
were added to REMSAs to increase the stringency of the assay.C, to determine if
the same RNA-binding protein interacts with both the 5- and 3-ends of SSAT,
competition studies were performed by addition of unlabeled RNA (100
molar excess) to the cytoplasmic extract prior to incubationwith 100,000 cpmof
32P-labeled P1–165 or P333–513 Riboprobes.
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regions interact with each other in vivo, as changes in either
region results in translation in the absence of DENSPM. Fur-
ther studies are required to identify the RNA-binding protein
involved in the translational repression of SSAT and to charac-
terize its interaction with each region of the transcript. This
work contributes to our growing understanding of the regula-
tion of SSAT expression, which is an emerging target for anti-
cancer drug development.
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